2025-05-02 09:18:45
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Rossari Biotech Ltd posts consolidated net profit of Rs. 25.68 crores in Q3FY23
Posted On : 2023-02-04 17:17:31( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 390.383 crores during the period ended December 31, 2022 as compared to Rs. 426.256 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 25.681 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 23.916 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 4.63 for the period ended December 31, 2022 as compared to Rs. 4.32 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹390.383 crs | ₹426.256 crs |  -8.42% |
| Net Profit | ₹25.681 crs | ₹23.916 crs |  7.38% |
| EPS | ₹4.63 | ₹4.32 | 7.18% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.390.383 crores during the period ended December 31, 2022 as compared to Rs.433.771 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.25.681 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.22.539 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.4.63 for the period ended December 31, 2022 as compared to Rs.4.07 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹390.383 crs | ₹433.771 crs | -10.00% |
| Net Profit | ₹25.681 crs | ₹22.539 crs | 13.94% |
| EPS | ₹4.63 | ₹4.07 | 13.76% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1252.093 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1054.066 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.78.278 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.73.290 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.14.14 for the 9 Months period ended December 31, 2022 as compared to Rs.13.29 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹1252.093 crs | ₹1054.066 crs | 18.79% |
| Net Profit | ₹78.278 crs | ₹73.290 crs | 6.81% |
| EPS | ₹14.14 | ₹13.29 | 6.40% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 690.40 as compared to the previous close of Rs. 690.20. The total number of shares traded during the day was 3488 in over 734 trades.
The stock hit an intraday high of Rs. 695.00 and intraday low of 680.25. The net turnover during the day was Rs. 2399860.00.
